A fourth shot of the COVID-19 Sinopharm vaccine will not provide any additional protection against the disease, according to a study from the Sun Yat-sen University in Guangzhou released earlier ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Sinopharm Group ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Morocco is already producing the Chinese Sinopharm vaccine, with more than three million doses being made per month. By next month it plans on producing five million doses and more than 20 million ...

Al-Monitor is an award-winning media outlet covering the Middle East, valued for its independence, diversity and analysis. It is read widely by US, international and Middle East decision makers at the ...

Argentine President Alberto Fernández and directors of the Chinese laboratory which produces the Sinopharm COVID-19 vaccine met Friday in Berlin in another stop of the head of state's tour.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...